New drug combo targets tough brain cancers in early trial
Disease control
UNKNOWN_STATUS
This early-phase study tests an experimental oral drug called CTO, alone or combined with standard treatments, in 100 adults with advanced solid tumors or aggressive brain cancers (glioblastoma). The main goal is to find the safest dose and understand side effects. Researchers wi…
Phase: PHASE1 • Sponsor: Tactical Therapeutics, Inc. • Aim: Disease control
Last updated May 07, 2026 18:41 UTC